Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40437, first published .
Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability

Journals

  1. McPherson S, Smith C, Hall L, Miguel A, Bowden T, Keever A, Schmidt A, Olson K, Rodin N, McDonell M, Roll J, LeBrun J. Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trial. Drug and Alcohol Dependence 2024;256:111099 View
  2. Nieto O, Rosen A, Kalmin M, Li L, Shoptaw S, Jenkins S, Zarei Ardestani Z, Tulu B. Facilitators and Challenges to Adoption of a Digital Health Tool for Opioid Use Disorder Treatment in Primary Care: Mixed Methods Study. Journal of Medical Internet Research 2025;27:e69953 View
  3. Kobson B, Hanley J, Mair A, Dima A, Rea N, Paterson R. Patients’ perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence. International Journal of Clinical Pharmacy 2025 View